Time to put those #selfies to good use
Its official, summer is here and there’s no better way to document all of the family fun you’re having than with a good ol’ selfie. And chances are you’ll post them on one of your social media profiles…so why not tag them with #VCSummerSelfie and be entered to win a GoPro Hero 4TM camera along with a 3-in-1 mount and a memory card (to store all those selfie photo-shoots!)? Read More
ViaCord Speaker Spotlight
Therapeutic Potential of Heterogeneous Cells Isolated Directly from Cord Tissue
Morey Kraus, Chief Scientific Officer
The International Society for Cellular Therapy (ISCT) is a global society of clinicians, regulators, technologists, and industry partners with a shared vision to translate cellular therapy into safe and effective therapies to improve patients’ lives. Each year ISCT gathers for an annual meeting that brings great minds together to share work and progress toward advancing therapies for the benefit of patients worldwide.
This year, over 1200 international delegates are expected to be in attendance at the 21st annual ISCT meeting. Attendees can expect to hear from clinicians, laboratory professionals, industry leaders from cellular therapy companies, and ViaCord’s very own Chief Scientific Officer, Morey Kraus! Not only is Morey part of the speaker program, he – along with a team from ViaCord – will also have an abstract poster on display.
Preeclampsia is a disorder that occurs in approximately 5-8% of all pregnancies.1 Characterized by high blood pressure and signs of damage to another organ system, often the kidneys, preeclampsia typically arises after 20 weeks of pregnancy.2 For a fraction of all cases – about 0.5% – preeclampsia results in the delivery of the baby before 34 weeks’ gestation. This is known as early onset preeclampsia. It can be more severe than preeclampsia and life-threatening in certain cases. Read More
Today’s guest post was written by Sarah Hughes, a mother of two and a preeclampsia survivor. In honor of Preeclampsia Awareness Month, Sarah has been kind enough to share her story. We want to thank Sarah for taking the time to help spread the word about this life-threatening condition that so many know nothing about. Here is her story…
During my pregnancy I researched all things baby. From the top of the line, safest car seats to what type of wheels I wanted on my stroller. I spent hours reciting my soon to be baby’s boy and girl name choices paired with my last name to be sure it fit well. What I didn’t research turned out to be the one thing that almost killed me…preeclampsia. Preeclampsia is a life-threatening disorder that occurs during pregnancy Read More
ViaCord Speaker Spotlight
Novel Applications for Cord Blood: Exploring Regenerative Properties
Kate Girard, RN MSN, Senior Principal Clinical Affairs Specialist
We are excited to share that ViaCord’s own Kate Girard is not only attending, but is also speaking at the Cord Blood World Europe Conference occurring in London this Wednesday and Thursday. We are excited that Kate is able to attend this meeting because it offers her an opportunity to educate other industry professionals as well as bring back valuable knowledge to the ViaCord research team.This conference is all about advancing cord blood medicine and learning about the latest developments in therapeutic applications for cord blood. Over the course of two days, cord blood bank representatives, clinicians, and researchers will all gather together to discuss how to build deposits, reduce the costs of banking, and increase utilization. Read More
A Pediatrician’s Perspective: Developmental Milestones Through
Baby’s First Year
Guest Post – Dr. Bruce Brovender
The American Academy of Pediatrics takes this question very seriously and has laid out guidelines for Pediatricians to follow. It is very important to be constantly vigilant at each well baby visit for potential problems. I have learned to always listen to parents who may have a concern about their child’s development.